CIDRAP newsletters options
(CIDRAP News) In one of the first large serologic studies of pandemic H1N1 infection, British researchers found that in areas hit hard during the first wave, one in three children were infected by the virus, ten times higher than surveillance estimates.
Only 3 months ago, here in the United States and many parts of the Northern Hemisphere we were experiencing the peak case occurrence of the second wave of the novel H1N1 influenza pandemic. Fearful parents were scrambling to find the precious few doses of vaccine available in their communities.
(CIDRAP News) A multi-national team of researchers has applied a new genomic tool to a 50-year-old bacterial foe, using minute mutations to track the spread of drug-resistant staph both across continents and within a single hospital.
Jan 21, 2010
No flu vaccine in Nigeria after first H1N1 death
Jan 20, 2010
(CIDRAP News) The H1N1 influenza pandemic brought no "devastating surprises," but what has surprised public health agencies is the public's lack of interest in getting vaccinated, Margaret Chan, director-general of the World Health Organization (WHO), said yesterday.
GSK vaccine sales lower than predicted
Jan 19, 2010
(CIDRAP News) During a week federal officials set aside to push flu immunization, a new report today reveals that pandemic vaccine uptake is low in two of the top priority groupsthose with chronic conditions and healthcare workers.
The report outlining the challenges public health officials face in vaccinating target groups came as federal officials released their latest estimates of pandemic flu cases, hospitalizations, and deaths.
(CIDRAP News) The use of adjuvanted vaccines, an unfamiliar technology, helped spark mistrust that may have contributed to the recent allegations in Europe that pharmaceutical companies manipulated governments and international agencies by hyping the H1N1 pandemic threat, according to a British market analyst who follows infectious disease issues.
Jan 14, 2010
(CIDRAP News) – The World Health Organization (WHO) and vaccine makers from Europe today defended themselves against the charges of some European officials that the agency was improperly influenced by vaccine companies and exaggerated the threat of the pandemic H1N1 virus.
(CIDRAP News) Leading public health officials and experts have sharply rejected charges from some European officials that pharmaceutical companies used exaggerated claims about the H1N1 pandemic threat to scare governments into buying unnecessary stockpiles of vaccines.
Jan 13, 2010
(CIDRAP News) Federal officials and representatives from some of the nation's biggest health advocacy groups today teamed up to push the importance of pandemic H1N1 vaccination for people who have chronic medical conditions such as asthma, diabetes, and cancer.
Jan 12, 2010
(CIDRAP News) The US government recently cut back its contract for H1N1 influenza vaccine from Australian-based CSL Biotherapies by about 60%, mainly as a result of delays related to the company's commitment to make vaccine for Australia first.
